TheFly.com
Start Free Trial
Open Search
keyboard_arrow_down
Type symbol to search
This symbol is non-existent:
List is empty.
Search
GANX
Gain Therapeutics
$
()
GANX
Gain Therapeutics announces preclinical data on class of allosteric regulators
GANX
12/1/2023 - 08:08am
Gain Therapeutics prices 2.2M shares at $2.005 in public offering
GANX
11/21/2023 - 08:58am
Fly Intel: After-Hours Movers
SYM
,
FEIM
,
MOR
…
11/20/2023 - 20:28pm
Gain Therapeutics files to sell common stock, no amount given
GANX
11/20/2023 - 16:04pm
Gain Therapeutics reports Q3 EPS (37c), consensus (45c)
GANX
11/14/2023 - 07:14am
Gain announces dosing of first two subjects in Phase 1 trial of GT-02287
GANX
10/4/2023 - 07:01am
Gain Therapeutics initiated with a Buy at Maxim
GANX
9/12/2023 - 07:34am
Gain Therapeutics announces preclinical data from drug candidate GT-02287
GANX
8/28/2023 - 07:02am
Gain Therapeutics expects cash to fund operations into Q3 of 2024
GANX
8/10/2023 - 07:14am
Gain Therapeutics announces upcoming milestones
GANX
8/10/2023 - 07:14am
Gain Therapeutics reports Q2 EPS (62c), consensus (31c)
GANX
8/10/2023 - 07:13am
Gain announces acceptance of late breaking abstract to present on GT-02287
GANX
8/7/2023 - 07:08am
Gain Therapeutics price target raised to $6 from $5.75 at Chardan
GANX
5/14/2023 - 20:43pm
Gain Therapeutics expects cash to fund operations into 3Q24
GANX
5/12/2023 - 08:08am
Gain Therapeutics reports Q1 EPS (43c), consensus (39c)
GANX
5/12/2023 - 08:07am
dynamic_feed
Breaking News
search
Search
menu
Menu